Liposome encapsulated berberine treatment attenuates cardiac dysfunction after myocardial infarction

Inflammation is a known mediator of adverse ventricular remodeling after myocardial infarction (MI) that may lead to reduction of ejection fraction and subsequent heart failure. Berberine is a isoquinoline quarternary alkaloid from plants that has been associated with anti-inflammatory, anti-oxidati...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of controlled release 2017-02, Vol.247, p.127-133
Hauptverfasser:	Allijn, Iris E., Czarny, Bertrand M.S., Wang, Xiaoyuan, Chong, Suet Yen, Weiler, Marek, da Silva, Acarilia Eduardo, Metselaar, Josbert M., Lam, Carolyn Su Ping, Pastorin, Giorgia, de Kleijn, Dominique P.V., Storm, Gert, Wang, Jiong-Wei, Schiffelers, Raymond M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Anti-Inflammatory Agents - administration & dosage Anti-Inflammatory Agents - therapeutic use Berberine Berberine - administration & dosage Berberine - therapeutic use Cardiac function Cardiotonic Agents - administration & dosage Cardiotonic Agents - therapeutic use Heart - drug effects Heart - physiopathology Inflammation Interleukin-6 - analysis Liposomes Male Mice Mice, Inbred C57BL Myocardial infarction Myocardial Infarction - drug therapy Myocardial Infarction - physiopathology RAW 264.7 Cells Ventricular Remodeling - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!